Home/ Supplements/ Coq10/ CoQ10 50 mg

CoQ10 50 mg

product on market Capsule Highland Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Coenzyme Q10 and alpha lipoic acid are supported by moderate evidence for their roles as antioxidants and cellular energy supporters. Lecithin serves as a phospholipid to aid in the absorption of these fat-soluble components. Research on these ingredients is well-documented, though the overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for CoQ10 50 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegetarian Capsule(s)
Serving Size
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

50 mg
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)
Lecithin
50 mg
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews

Other Ingredients

Calcium Phosphate Vegetable Cellulose Cellulose Magnesium Trisilicate Silica Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

One capsule daily, as a dietary supplement.

Warnings & Precautions

Contains soy, from lecithin.

Formulation Notes

CoQ10 50 mg. (emulsified) plus Alpha Lipoic Acid

No corn, salt, yeast, gluten, milk & egg products, sugar, starch, or preservatives.

Contains soy, from lecithin.

Additional Information

Also available in 60 count

GMP Quality Assured Earth Friendly

PR 1353

Metadata

Product Details

UPC / SKU7 68305 13533 8
DSLD Entry Date2017-10-21
Product TypeOther Combinations
FormCapsule
DSLD ID79748
Data Updated2026-04-11
Research

Research Evidence

202
Research Sources
55
Avg Quality
86
Meta Analysis
62
Systematic Review
28
Rct
17
Clinical Trial
4
Regulatory Source
2
Other
1
Narrative Review
1
Openfda Safety
A Coenzyme Q10 for heart failure
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Cardioprotective interventions for cancer patients receiving anthracyclines
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis
Meta Analysis BMJ open 2021 PubMed DOI
A Effects of coenzyme Q10 supplementation on statin-induced myopathy: a meta-analysis of randomized controlled trials
Meta Analysis Irish journal of medical science 2022 PubMed DOI
B Cardioprotective interventions for cancer patients receiving anthracyclines
Meta Analysis The Cochrane database of systematic reviews 2008 PubMed DOI
B Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Efficacy and Safety of Coenzyme Q10 Supplementation in the Treatment of Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis
Meta Analysis Reproductive sciences (Thousand Oaks, Calif.) 2023 PubMed DOI
B Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials
Meta Analysis International journal of molecular sciences 2020 PubMed DOI
B Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis
Meta Analysis Journal of nutritional science 2025 PubMed DOI
B Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
View all evidence for Coq10 →
Compare

Similar Products

View all Coq10 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.